Arkolith/Insider Trading/AVDL/Form 4

McCamish Mark Anthony

DirectorAVADEL PHARMACEUTICALS PLC (AVDL) · full profile →Form 4 · filed Feb 6, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 4, 2026Gift(G)67K—$067K
Feb 4, 2026Gift(G)67K—$00

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-011511) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML